NCT01535001

Brief Summary

The purpose of this study is to test whether an algorithm for systematic non-surgical treatment consisting of corrective insoles, neuromuscular training, weight loss, patient education and pharmacological treatment with paracetamol, non steroidal anti inflammatory drugs (NSAIDs) and Pantoprazole provides further improvement in pain, function and quality of life than standard non-surgical treatment (information on the disease and how to treat it) in patients with knee osteoarthritis. The H1-hypothesis is that the treatment algorithm results in a greater increase in quality of life and functional capacity and greater reduction in pain than standard treatment at the primary endpoint, which is follow-up 12months after the start of the treatment. See statistical analysis plan available under "Links" for further description of the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2012

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

February 9, 2012

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 17, 2012

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

January 27, 2016

Completed
Last Updated

October 16, 2017

Status Verified

September 1, 2017

Enrollment Period

2.6 years

First QC Date

February 9, 2012

Results QC Date

December 19, 2015

Last Update Submit

September 14, 2017

Conditions

Keywords

Osteoarthritis, KneeTreatment OutcomeTime FactorsRehabilitationCombined Modality TherapyMiddle AgedAgedAged, 80 and overMaleFemaleHumansAnalysis of Variance

Outcome Measures

Primary Outcomes (1)

  • Change From Baseline in KOOS4 (Knee Injury and Osteoarthritis Outcome Score)

    The average score for four of the five KOOS subscales, covering pain, symptoms, difficulties in functions of daily living, and quality of life (KOOS4), with scores ranging from 0 (worst) to 100 (best). Between group comparisons of treatment effect (change in KOOS4 from baseline to 1 year follow-up) will be dependent on data distribution. We expect the change to be normally distributed and analysis will be made using a mixed model ANOVA with subject being a random factor and visit (baseline, 3, 6 and 12 months), treatment arm (TKA + MEDIC, MEDIC) and site (Frederikshavn, Farsoe) being fixed factors. Baseline KOOS4 will be a covariate. Furthermore interactions between the fixed factors will be included in the model. P-values and 95% CI will be presented to assess superiority.

    Primary: 12months.

Secondary Outcomes (7)

  • Change From Baseline in EQ-5D

    Primary: 12months.

  • Change From Baseline in 20-meter Walk

    Primary: 12months.

  • Change in the Five KOOS Subscale Scores From Baseline

    Primary: 12 months.

  • Weight Change in kg From Baseline

    Primary: 12months.

  • Proportion of Users of Pain Medication

    Baseline and 12months.

  • +2 more secondary outcomes

Other Outcomes (1)

  • Exploratory Outcomes

    Baseline, 3months, 6months, 12months and 24months

Study Arms (2)

MEDIC

ACTIVE COMPARATOR

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months.

Other: Neuromuscular training (NEMEX-TJR)Drug: ParacetamolDrug: BuranaDrug: PantoprazoleBehavioral: Dietary counselingBehavioral: Patient educationOther: Insoles

Standard treatment

ACTIVE COMPARATOR

Information on knee osteoarthritis, and on what they can do to treat the disorder and prevent it from being worse.

Behavioral: Information

Interventions

60min. of neuromuscular training two times a week for 3 months (12 weeks) using the neuromuscular training program called NEMEX-TJR.

Also known as: No other
MEDIC
InformationBEHAVIORAL

Information on knee osteoarthritis, and on what they can do to treat the disorder and prevent it from being worse. Information will be given in a leaflet.

Also known as: No other
Standard treatment

1 g x 4/day

Also known as: No other
MEDIC
BuranaDRUG

400 mg x 3/day for three weeks

Also known as: No other
MEDIC

20mg x 1/day for three weeks

Also known as: No other
MEDIC

For participants with a BMI equal to or \>25. The dietitian initiates a 3-month intervention that provides instruction and guidance in relation to diet and plans the number of visits according to the individual participant needs.

Also known as: No other
MEDIC

The aim is to strengthen the participant's involvement in the treatment, so the participant will be in a position to handle, master and act reasonable in relation to their knee OA. This aspect of the intervention is based on principles from The Chronic Disease Self-Management Program, "Lær at leve med kronisk sygdom (Learn to live with chronic illness)" by The National Board of Health, Denmark and "Artrosskolan Spenshult" in Sweden.

Also known as: No other
MEDIC
InsolesOTHER

The position of the knee is assessed using Single Leg Mini Squat. On the basis of this test it is decided which of two types of insoles (Formthotics System) the participant should have (neutral with a lateral wedge or neutral). The participants will be advised to use the insoles in all shoes.

Also known as: No other
MEDIC

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Knee-OA detected by x-ray (Kellgren \& Lawrence grade 1 or greater)
  • KOOS4 of ≤ 75
  • Considered not to be a candidate for Total Knee Replacement (TKR) by the orthopedic surgeon.
  • The participant is \> 18 years of age.
  • The participant can provide relevant and adequate, informed consent.

You may not qualify if:

  • Prior TKA ipsilateral
  • Rheumatoid arthritis
  • Mean VAS \> 60mm the last week on a 0-100mm scale
  • Possible pregnancy or planning pregnancy;
  • Inability to comply with the protocol;
  • Inadequacy in written and spoken Danish.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Department of Occupational and Physiotherapy, Aalborg Hospital-Aarhus University Hospital

Aalborg, 9000, Denmark

Location

Farsoe Hospital

Farsø, 9640, Denmark

Location

Vendsyssel Hospital, Frederikshavn

Frederikshavn, 9900, Denmark

Location

Related Publications (14)

  • Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, Gunther K, Hauselmann H, Herrero-Beaumont G, Kaklamanis P, Lohmander S, Leeb B, Lequesne M, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Serni U, Swoboda B, Verbruggen G, Zimmerman-Gorska I, Dougados M; Standing Committee for International Clinical Studies Including Therapeutic Trials ESCISIT. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003 Dec;62(12):1145-55. doi: 10.1136/ard.2003.011742.

    PMID: 14644851BACKGROUND
  • Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010 Apr;18(4):476-99. doi: 10.1016/j.joca.2010.01.013. Epub 2010 Feb 11.

    PMID: 20170770BACKGROUND
  • Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008 Feb;16(2):137-62. doi: 10.1016/j.joca.2007.12.013.

    PMID: 18279766BACKGROUND
  • Fortin PR, Penrod JR, Clarke AE, St-Pierre Y, Joseph L, Belisle P, Liang MH, Ferland D, Phillips CB, Mahomed N, Tanzer M, Sledge C, Fossel AH, Katz JN. Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee. Arthritis Rheum. 2002 Dec;46(12):3327-30. doi: 10.1002/art.10631.

    PMID: 12483739BACKGROUND
  • Rossi MD, Eberle T, Roche M, Waggoner M, Blake R, Burwell B, Baxter A. Delaying knee replacement and implications on early postoperative outcomes: a pilot study. Orthopedics. 2009 Dec;32(12):885. doi: 10.3928/01477447-20091020-06.

    PMID: 19968215BACKGROUND
  • National Board of Health, Denmark. Referenceprogram for knæartrose. Copenhagen: National Board of Health, Denmark; 2007. [22.02.2010] found at: http://www.sst.dk/publ/Publ2007/PLAN/SfR/Refprg_knaeartrose.pdf

    BACKGROUND
  • Skou ST, Rasmussen S, Laursen MB, Rathleff MS, Arendt-Nielsen L, Simonsen O, Roos EM. The efficacy of 12 weeks non-surgical treatment for patients not eligible for total knee replacement: a randomized controlled trial with 1-year follow-up. Osteoarthritis Cartilage. 2015 Sep;23(9):1465-75. doi: 10.1016/j.joca.2015.04.021. Epub 2015 Apr 30.

    PMID: 25937024BACKGROUND
  • Larsen JB, Roos EM, Laursen M, Holden S, Johansen MN, Rathleff MS, Arendt-Nielsen L, Rasmussen S, Skou ST. Five-year follow-up of patients with knee osteoarthritis not eligible for total knee replacement: results from a randomised trial. BMJ Open. 2022 Nov 25;12(11):e060169. doi: 10.1136/bmjopen-2021-060169.

  • Skou ST, Roos EM, Laursen M, Arendt-Nielsen L, Rasmussen S, Simonsen O, Ibsen R, Larsen AT, Kjellberg J. Cost-effectiveness of 12 weeks of supervised treatment compared to written advice in patients with knee osteoarthritis: a secondary analysis of the 2-year outcome from a randomized trial. Osteoarthritis Cartilage. 2020 Jul;28(7):907-916. doi: 10.1016/j.joca.2020.03.009. Epub 2020 Mar 31.

  • Skou ST, Roos EM, Laursen MB, Rathleff MS, Arendt-Nielsen L, Rasmussen S, Simonsen O. Total knee replacement and non-surgical treatment of knee osteoarthritis: 2-year outcome from two parallel randomized controlled trials. Osteoarthritis Cartilage. 2018 Sep;26(9):1170-1180. doi: 10.1016/j.joca.2018.04.014. Epub 2018 May 1.

  • Arendt-Nielsen L, Simonsen O, Laursen MB, Roos EM, Rathleff MS, Rasmussen S, Skou ST. Pain and sensitization after total knee replacement or nonsurgical treatment in patients with knee osteoarthritis: Identifying potential predictors of outcome at 12 months. Eur J Pain. 2018 Jul;22(6):1088-1102. doi: 10.1002/ejp.1193. Epub 2018 Feb 15.

  • Skou ST, Rasmussen S, Simonsen O, Roos EM. Knee Confidence as It Relates to Self-reported and Objective Correlates of Knee Osteoarthritis: A Cross-sectional Study of 220 Patients. J Orthop Sports Phys Ther. 2015 Oct;45(10):765-71. doi: 10.2519/jospt.2015.5864. Epub 2015 Aug 24.

  • Skou ST, Roos EM, Simonsen O, Laursen MB, Rathleff MS, Arendt-Nielsen L, Rasmussen S. The efficacy of non-surgical treatment on pain and sensitization in patients with knee osteoarthritis: a pre-defined ancillary analysis from a randomized controlled trial. Osteoarthritis Cartilage. 2016 Jan;24(1):108-16. doi: 10.1016/j.joca.2015.07.013. Epub 2015 Aug 1.

  • Skou ST, Roos EM, Laursen MB, Rathleff MS, Arendt-Nielsen L, Simonsen O, Rasmussen S. Efficacy of multimodal, systematic non-surgical treatment of knee osteoarthritis for patients not eligible for a total knee replacement: a study protocol of a randomised controlled trial. BMJ Open. 2012 Nov 14;2(6):e002168. doi: 10.1136/bmjopen-2012-002168. Print 2012.

Related Links

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

AcetaminophenPantoprazoleNutrition AssessmentPatient Education as TopicFoot Orthoses

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines2-PyridinylmethylsulfinylbenzimidazolesSulfoxidesSulfur CompoundsPyridinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsBenzimidazolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingData CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationEpidemiologic MeasurementsPublic HealthEnvironment and Public HealthHealth EducationPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesOrthotic DevicesOrthopedic EquipmentSurgical EquipmentEquipment and Supplies

Results Point of Contact

Title
Dr. Søren T. Skou
Organization
Aalborg University Hospital

Study Officials

  • Søren T. Skou, PhD-student

    Orthopaedic Research Unit, Aalborg University Hospital, Denmark

    PRINCIPAL INVESTIGATOR
  • Ewa M. Roos, PhD

    Research Unit for Musculoskeletal Function and Physiotherapy, Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark, Denmark

    STUDY CHAIR
  • Lars Arendt-Nielsen, Dr.Sci.Med.

    Center for Sensory-Motor Interaction (SMI), Department of Health Sciences and Technology, Aalborg University

    STUDY CHAIR
  • Mogens B. Laursen, PhD

    Orthopaedic Surgery Research Unit, Aalborg University Hospital, Denmark

    STUDY CHAIR
  • Sten Rasmussen, M.D.

    Orthopaedic Surgery Research Unit, Aalborg University Hospital, Denmark

    STUDY CHAIR
  • Michael S. Rathleff, PhD-student

    Orthopaedic Surgery Research Unit, Aalborg University Hospital, Denmark

    STUDY CHAIR
  • Ole H. Simonsen, Dr.Sci.Med.

    Orthopaedic Surgery Research Unit, Aalborg University Hospital, Denmark

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 9, 2012

First Posted

February 17, 2012

Study Start

February 1, 2012

Primary Completion

September 1, 2014

Study Completion

September 1, 2014

Last Updated

October 16, 2017

Results First Posted

January 27, 2016

Record last verified: 2017-09

Locations